Indaptus Therapeutics, Inc.(INDP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INDP Indaptus Therapeutics, Inc.

交易中 10-28 10:59:30 EDT

3.38

+0.07

+2.22%

最高3.45	最低3.28	成交量6.25万
今开3.30	昨收3.31	日振幅5.14%
总市值4.49亿	流通市值8,445万	总股本1.33亿
成交额21.01万	换手率0.25%	流通股本2,500万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INDP","market":"US","secType":"STK","nameCN":"Indaptus Therapeutics, Inc.","latestPrice":3.3785,"timestamp":1793199568197,"preClose":3.305,"halted":0,"volume":62509,"delay":0,"changeRate":0.022239031770045287,"floatShares":24997199,"shares":133000000,"eps":-0.470911,"marketStatus":"交易中","change":0.0735,"latestTime":"10-28 10:59:30 EDT","open":3.3,"high":3.45,"low":3.28,"amount":210146.21294770003,"amplitude":0.051437,"askPrice":3.38,"askSize":154,"bidPrice":3.3,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-0.470911,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1793217600000},"marketStatusCode":2,"adr":0,"listingDate":1438660800000,"exchange":"NASDAQ","adjPreClose":3.305,"preHourTrading":{"tag":"盘前","latestPrice":3.5,"preClose":3.305,"latestTime":"09:26 EDT","volume":2030,"amount":7023.3998870000005,"timestamp":1793194010134,"change":0.195,"changeRate":0.059002,"amplitude":0.060514},"postHourTrading":{"tag":"盘后","latestPrice":3.3,"preClose":3.305,"latestTime":"19:30 EDT","volume":415,"amount":1377.9693,"timestamp":1793143806408,"change":-0.005,"changeRate":-0.001513,"amplitude":0.003026},"volumeRatio":0.769581},"requestUrl":"/m/hq/s/INDP","defaultTab":"news","newsList":[{"id":"1191862503","title":"Indaptus Therapeutics提交SEC文件：拟由售股股东转售最多58,895,000股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1191862503","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191862503?lang=zh_cn&edition=full","pubTime":"2026-08-18 05:03","pubTimestamp":1787000618,"startTime":"0","endTime":"0","summary":"Indaptus Therapeutics已向美国证券交易委员会提交了一份重要文件，披露了一项涉及售股股东转售至多58,895,000股普通股的拟议安排。据悉，此次转售计划完全由现有售股股东主导，公司本身并未参与发行新股。如此大规模的股份转售，往往引发市场对流动性和股价短期波动的密切关注。透过这一SEC备案文件，市场参与者得以窥见公司股权分布的潜在变化。对于Indaptus Therapeutics而言，这一举措或为其股东提供退出或调整持仓的窗口，同时也可能为股票交易带来更活跃的市场氛围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179151924","title":"Indaptus Therapeutics提交SEC文件：特定股东申请转售最多1886万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1179151924","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179151924?lang=zh_cn&edition=full","pubTime":"2026-06-27 05:24","pubTimestamp":1782509059,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件显示，生物制药公司Indaptus Therapeutics, Inc. 已就其特定股东申请转售公司普通股一事完成备案。该文件指出，这些售股股东计划在符合相关证券法规的前提下，于公开市场转售其持有的公司普通股，总计数量最高可达1886万股。此举通常意味着部分早期投资者或特定持股方可能寻求变现其投资。市场参与者往往会关注此类备案，以评估潜在的市场供应增加及股东持股结构的变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517216678","title":"Indaptus Therapeutics, Inc.盘中异动 早盘急速下挫5.50%报0.767美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517216678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517216678?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:50","pubTimestamp":1741272623,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时50分，Indaptus Therapeutics, Inc.股票出现异动，股价大幅下跌5.50%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃，换手率分别为1344.02%、384.12%、63.26%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为33.60%、31.58%、28.10%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225024abeb7cfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225024abeb7cfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INDP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514090926","title":"Indaptus Therapeutics, Inc.盘中异动 早盘股价大跌8.83%报0.702美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514090926?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:44","pubTimestamp":1740494684,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时44分，Indaptus Therapeutics, Inc.股票出现波动，股价急速跳水8.83%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为860.28%、624.94%、533.26%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.，振幅分别为100.27%、46.65%、33.50%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224445962ff5a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224445962ff5a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512481849","title":"Indaptus Therapeutics, Inc.盘中异动 快速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512481849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512481849?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:59","pubTimestamp":1739980755,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时59分，Indaptus Therapeutics, Inc.股票出现波动，股价急速下挫5.06%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为557.81%、242.30%、106.56%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Aditxt, Inc.、Allogene Therapeutics, Inc.，振幅分别为207.68%、48.18%、36.97%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235915abd51092&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235915abd51092&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511524821","title":"Indaptus Therapeutics, Inc.盘中异动 股价大涨9.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511524821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511524821?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:36","pubTimestamp":1739461011,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时36分，Indaptus Therapeutics, Inc.股票出现异动，股价快速拉升9.14%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Nutriband Inc C/Wts 涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Moleculin Biotech, Inc.较为活跃，换手率分别为2411.28%、1145.01%、783.77%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为454.76%、95.15%、92.30%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233651a244b9a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233651a244b9a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INDP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507624902","title":"Indaptus Therapeutics, Inc.盘中异动 大幅跳水5.90%报0.866美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507624902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507624902?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:03","pubTimestamp":1738249398,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时03分，Indaptus Therapeutics, Inc.股票出现异动，股价大幅下跌5.90%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为1274.60%、165.05%、164.47%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Kazia Therapeutics Limited、Alterity Therapeutics Limited，振幅分别为56.41%、42.03%、36.77%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130230318a2345acb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130230318a2345acb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502671348","title":"Indaptus Therapeutics, Inc.盘中异动 快速下挫5.14%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502671348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502671348?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:38","pubTimestamp":1736519888,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时38分，Indaptus Therapeutics, Inc.股票出现波动，股价急速下挫5.14%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。其相关个股中，Precision Biosciences, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Zyversa Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1014.72%、153.12%、148.01%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zyversa Therapeutics, Inc.，振幅分别为30.12%、25.00%、24.58%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011022380895ff6ea4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011022380895ff6ea4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493420790","title":"Indaptus Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493420790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493420790?lang=zh_cn&edition=full","pubTime":"2024-12-24 04:18","pubTimestamp":1734985082,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日04时18分，Indaptus Therapeutics, Inc.股票出现波动，股价急速跳水5.12%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Traws Pharma, Inc.、Sol-Gel Technologies Ltd.、Rapt Therapeutics, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Traws Pharma, Inc.、Gt Biopharma, Inc.较为活跃，换手率分别为1024.71%、915.17%、914.36%，振幅较大的相关个股有Sol-Gel Technologies Ltd.、Traws Pharma, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为180.58%、157.37%、148.33%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224041802a2059a44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224041802a2059a44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492441441","title":"Indaptus Therapeutics, Inc.盘中异动 股价大涨7.08%报0.953美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492441441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492441441?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:34","pubTimestamp":1734705251,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时34分，Indaptus Therapeutics, Inc.股票出现异动，股价急速上涨7.08%。截至发稿，该股报0.953美元/股，成交量2193股，换手率0.02%，振幅0.00%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223411a1fe254a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223411a1fe254a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492995759","title":"Indaptus Therapeutics, Inc.盘中异动 快速下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492995759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492995759?lang=zh_cn&edition=full","pubTime":"2024-12-18 01:50","pubTimestamp":1734457846,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日01时50分，Indaptus Therapeutics, Inc.股票出现异动，股价急速跳水5.09%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Portage Biotech Inc.、Marker Therapeutics, Inc.、Os Therapies Incorporated涨幅较大，Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Polyrizon Ltd.较为活跃，换手率分别为2678.78%、374.13%、146.78%，振幅较大的相关个股有Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为211.53%、153.77%、95.10%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218015047984c9318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218015047984c9318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489143171","title":"Indaptus Therapeutics, Inc.盘中异动 股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489143171","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2489143171?lang=zh_cn&edition=full","pubTime":"2024-12-05 02:37","pubTimestamp":1733337420,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日02时37分，Indaptus Therapeutics, Inc.股票出现异动，股价大幅跳水5.27%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Exicure, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为4251.05%、276.78%、142.73%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为548.98%、287.57%、64.57%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205023700971baaf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205023700971baaf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INDP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488672225","title":"Indaptus Therapeutics, Inc.盘中异动 股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488672225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488672225?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:31","pubTimestamp":1733149902,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时31分，Indaptus Therapeutics, Inc.股票出现波动，股价急速拉升5.88%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Purple Biotech Ltd、Senti Biosciences, Inc.、Revelation Biosciences, Inc.较为活跃，换手率分别为645.52%、638.95%、201.10%，振幅较大的相关个股有Senti Biosciences, Inc.、Cabaletta Bio, Inc.、Organovo Holdings, Inc.，振幅分别为17.59%、9.69%、7.80%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223142abf0008b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223142abf0008b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486332700","title":"Indaptus Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486332700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486332700?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:31","pubTimestamp":1732545099,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时31分，Indaptus Therapeutics, Inc.股票出现波动，股价急速拉升5.00%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Scholar Rock Holding Corporation、Citius Pharmaceuticals, Inc.、Bridgebio Pharma, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为85.54%、53.40%、33.85%，振幅较大的相关个股有Werewolf Therapeutics, Inc.、Kodiak Sciences Inc、Celcuity Inc.，振幅分别为103.16%、102.58%、102.58%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223140abddf9db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223140abddf9db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","INDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484100676","title":"Indaptus Therapeutics, Inc.盘中异动 快速拉升8.11%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484100676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484100676?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:40","pubTimestamp":1731940825,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时40分，Indaptus Therapeutics, Inc.股票出现异动，股价急速上涨8.11%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为537.61%、294.83%、224.98%，振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为98.44%、62.38%、42.18%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224025971a72d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224025971a72d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483640658","title":"Indaptus Therapeutics, Inc.2024财年第三财季实现净利润-3.07百万美元，同比增加21.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483640658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483640658?lang=zh_cn&edition=full","pubTime":"2024-11-14 08:02","pubTimestamp":1731542536,"startTime":"0","endTime":"0","summary":"11月14日，Indaptus Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-3.07百万美元，同比增加21.68%；其中营业收入为0.00美元，每股基本收益为-0.32美元。从资产负债表来看，Indaptus Therapeutics, Inc.总负债2.24百万美元，其中短期债务103982.00美元，资产负债比为3.68，流动比率为3.43。机构评级：截至2024年11月14日，当前有2家机构对Indaptus Therapeutics, Inc.目标价做出预测，其中目标均价为8.50美元，其中最低目标价为5.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080224a235596f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080224a235596f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482381807","title":"Indaptus Therapeutics, Inc.盘中异动 大幅上涨7.56%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482381807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482381807?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:35","pubTimestamp":1731335742,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时35分，Indaptus Therapeutics, Inc.股票出现波动，股价急速上涨7.56%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Revelation Biosciences, Inc.涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为416.73%、147.53%、73.90%，振幅较大的相关个股有天演药业、Windtree Therapeutics, Inc.、Cingulate Inc.，振幅分别为109.34%、109.04%、107.06%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223542a22ce663&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223542a22ce663&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481022381","title":"Indaptus Therapeutics, Inc.盘中异动 早盘急速拉升9.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481022381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481022381?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:34","pubTimestamp":1731076467,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时34分，Indaptus Therapeutics, Inc.股票出现异动，股价快速拉升9.66%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.、Poseida Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为398.37%、17.89%、15.00%，振幅较大的相关个股有Cardiff Oncology, Inc.、Rigel Pharmaceuticals, Inc.、Anebulo Pharmaceuticals, Inc.，振幅分别为18.09%、16.52%、14.96%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822342795bdef90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822342795bdef90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481182151","title":"Indaptus Therapeutics, Inc.盘中异动 早盘股价大涨7.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481182151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481182151?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:18","pubTimestamp":1730992739,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时18分，Indaptus Therapeutics, Inc.股票出现波动，股价急速拉升7.76%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Ensysce Biosciences, Inc.、Celularity Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为614.84%、125.75%、91.59%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Celularity Inc.、Ensysce Biosciences, Inc.，振幅分别为68.89%、59.31%、57.79%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723185998e413ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723185998e413ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2478348675","title":"Indaptus Therapeutics, Inc.盘中异动 股价大跌7.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478348675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2478348675?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:32","pubTimestamp":1730122376,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时32分，Indaptus Therapeutics, Inc.股票出现异动，股价急速下挫7.41%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213256a1f24daf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213256a1f24daf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.indaptusrx.com","stockEarnings":[{"period":"1week","weight":0.1166},{"period":"1month","weight":-0.1416},{"period":"3month","weight":0.8159},{"period":"6month","weight":0.1804},{"period":"1year","weight":-0.069},{"period":"ytd","weight":0.1357}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0551},{"period":"6month","weight":0.071},{"period":"1year","weight":0.1232},{"period":"ytd","weight":0.1287}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Indaptus Therapeutics, Inc.于2021年2月24日在特拉华州注册成立。该公司是一家临床生物技术公司，开发了一种基于减毒、灭活的革兰氏阴性菌的全身性抗癌和抗病毒免疫疗法。其主要候选药物Decoy20在针对晚期实体瘤的1期试验中进行了评估，但进一步的临床开发已停止。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.037296},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.000875},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.06305},{"month":4,"riseRate":0.363636,"avgChangeRate":0.020664},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.084502},{"month":6,"riseRate":0.545455,"avgChangeRate":0.062667},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.113374},{"month":8,"riseRate":0.363636,"avgChangeRate":0.023187},{"month":9,"riseRate":0.416667,"avgChangeRate":0.033186},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.046598},{"month":11,"riseRate":0.272727,"avgChangeRate":-0.057102},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.026598}],"exchange":"NASDAQ","name":"Indaptus Therapeutics, Inc.","nameEN":"Indaptus Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Indaptus Therapeutics, Inc.(INDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Indaptus Therapeutics, Inc.(INDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Indaptus Therapeutics, Inc.,INDP,Indaptus Therapeutics, Inc.股票,Indaptus Therapeutics, Inc.股票老虎,Indaptus Therapeutics, Inc.股票老虎国际,Indaptus Therapeutics, Inc.行情,Indaptus Therapeutics, Inc.股票行情,Indaptus Therapeutics, Inc.股价,Indaptus Therapeutics, Inc.股市,Indaptus Therapeutics, Inc.股票价格,Indaptus Therapeutics, Inc.股票交易,Indaptus Therapeutics, Inc.股票购买,Indaptus Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Indaptus Therapeutics, Inc.(INDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Indaptus Therapeutics, Inc.(INDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}